Trials / Completed
CompletedNCT00306683
Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary Lesions
Clinical Assessment of the Treatment With Diazoxide in Children Suffering From Obesity and Hyperinsulinemia Secondary to Surgery of Hypothalamic-pituitary Lesions
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Academic / Other
- Sex
- All
- Age
- 6 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
In children treated for intracranial lesions, the 2 factors of the obesity are : the location of the lesion (hypothalamic-pituitary region) and craniopharyngiomas
Detailed description
Approximately 80 % of the hypothalamic-pituitary lesions that occur in children are craniopharyngiomas with one or three cases per 1 million children each year. One major problem remains unsolved : the obesity This study is performed to optimize the management of the children with hypothalamic-pituitary lesions by reducing the hyperinsulinemia due to the lesion and the surgery
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DIAZOXIDE |
Timeline
- Start date
- 2006-04-01
- Primary completion
- 2009-04-01
- Completion
- 2009-04-01
- First posted
- 2006-03-24
- Last updated
- 2011-02-18
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00306683. Inclusion in this directory is not an endorsement.